{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-051931","form_type":"8-K","ticker":"CC","cik":"0001627223","company_name":"Chemours Co","filed_at":"2024-02-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.857065+00:00","generated_at":"2026-06-05T06:44:08.244968+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"negative","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"Chemours places CEO, CFO, and CAO on leave; appoints interim leaders","bullets":["CEO Mark Newman, CFO Jonathan Lock, and CAO Camela Wisel placed on administrative leave pending Audit Committee review.","Denise Dignam, President of Titanium Technologies, appointed Interim CEO effective Feb 28, 2024.","Matthew Abbott, SVP & Chief Enterprise Transformation Officer, appointed Interim CFO.","Administrative leave relates to ongoing Audit Committee review of preliminary 2023 financial estimates."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-051931","json":"https://secwatch.observer/filing/0001193125-24-051931.json","markdown":"https://secwatch.observer/filing/0001193125-24-051931.md","text":"https://secwatch.observer/filing/0001193125-24-051931.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1627223/000119312524051931/0001193125-24-051931-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1627223/000119312524051931/d777505d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T06:44:08.244968+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0c7e9a0990","claim":"Camela Wisel departed as Vice President, Controller and Principal Accounting Officer at Chemours Co.","evidence_excerpt":"the Board placed President and Chief Executive Officer Mark Newman, Senior Vice President and Chief Financial Officer Jonathan Lock and Vice President, Controller and Principal Accounting Officer Camela Wisel on administrative leave","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1627223/000119312524051931/0001193125-24-051931-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"placed on administrative leave"},{"label":"Role","value":"Vice President, Controller and Principal Accounting Officer"}],"fact_type":"executive_change"},{"claim_id":"12da8ca608","claim":"Jonathan Lock departed as Senior Vice President and Chief Financial Officer at Chemours Co.","evidence_excerpt":"the Board placed President and Chief Executive Officer Mark Newman, Senior Vice President and Chief Financial Officer Jonathan Lock and Vice President, Controller and Principal Accounting Officer Camela Wisel on administrative leave","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1627223/000119312524051931/0001193125-24-051931-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"placed on administrative leave"},{"label":"Role","value":"Senior Vice President and Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"689a8b38b4","claim":"Mark Newman departed as President and Chief Executive Officer at Chemours Co.","evidence_excerpt":"the Board placed President and Chief Executive Officer Mark Newman, Senior Vice President and Chief Financial Officer Jonathan Lock and Vice President, Controller and Principal Accounting Officer Camela Wisel on administrative leave","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1627223/000119312524051931/0001193125-24-051931-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"placed on administrative leave"},{"label":"Role","value":"President and Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"8e04ca830f","claim":"Matthew Abbott was appointed as Interim Chief Financial Officer at Chemours Co.","evidence_excerpt":"Matthew Abbott as the Interim Chief Financial Officer","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1627223/000119312524051931/0001193125-24-051931-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Interim Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"d8be1c5adc","claim":"Denise Dignam was appointed as Interim Chief Executive Officer at Chemours Co.","evidence_excerpt":"appointed Denise Dignam as the Interim Chief Executive Officer","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1627223/000119312524051931/0001193125-24-051931-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Interim Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}